Trial Profile
A Phase 2 Study of Recombinant Human Thrombin (rThrombin) Administered Using a Spray Applicator in Subjects Undergoing Autologous Skin Grafting Following Burn or Traumatic Skin Injury
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Thrombin alfa (Primary)
- Indications Surgical blood loss
- Focus Therapeutic Use
- Sponsors ZymoGenetics
- 28 May 2014 New trial record